NTHI ▲ +0.2% - NeOnc Technologies Holdings, Inc. $NTHI - NeOnc' Phase 2 Data Could Put Cancer on the Ropes NeOnc Technologies Holdings shares rose 0.2% following the release of Phase 2 data for its cancer treatment candidate. Positive clinical trial results can advance a drug's path toward regulatory approval and potential commercialization, which typically supports investor sentiment in early-stage biotech companies. 08-SEP-2026 08:39 AM ET